LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 34 | -99.2% | 0.00% | – |
| Q3 2018 | $48,000 | -2.0% | 4,462 | +8.2% | 0.00% | – |
| Q2 2018 | $49,000 | – | 4,122 | +7394.5% | 0.00% | – |
| Q1 2018 | $0 | – | 55 | -19.1% | 0.00% | – |
| Q4 2017 | $0 | – | 68 | +74.4% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 39 | -77.7% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 175 | -28.0% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 243 | -3.6% | 0.00% | – |
| Q1 2016 | $3,000 | 0.0% | 252 | +3.7% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 243 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | +50.0% | 243 | +3.4% | 0.00% | – |
| Q2 2015 | $2,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $78,084,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $1,039,349,000 | 20.58% |
| NEA Management Company, LLC | 2,382,286 | $43,048,000 | 1.93% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $645,000 | 1.72% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 809,666 | $14,631,000 | 0.67% |
| MOODY ALDRICH PARTNERS LLC | 42,180 | $762,000 | 0.53% |
| Cupps Capital Management, LLC | 62,549 | $1,130,000 | 0.49% |
| BRIDGER MANAGEMENT, LLC | 336,966 | $6,089,000 | 0.41% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 258,353 | $4,668,000 | 0.34% |
| Round Table Services, LLC | 21,611 | $391,000 | 0.23% |